Lactobacillus Ferment

Clinically validated postbiotic with documented S. epidermidis proliferation increase of approximately 34%. Acidic fermentation byproducts (lactic acid, short-chain fatty acids) actively maintain the skin acid mantle at optimal pH 4.5–5.5 range, creating systemic unfavorable conditions for opportunistic pathogens. 2023 split-face study shows 41% IL-1α/TNF-α reduction when combined with Bifida Ferment Lysate. Inter-batch variability is the primary quality challenge; standardized fermentation parameters and batch-specific bioactive profiling are critical for reproducible clinical outcomes.

CIR June 2025 Final Safety Assessment: safe as used in cosmetics at current concentrations.